Blood Cancer Journal (Dec 2023)
Myeloid neoplasm occurrence during stable molecular remission of NPM1-mutated AML: are we facing secondary disease or AML relapse?
- Carlotta Giupponi,
- Diego Bertoli,
- Erika Borlenghi,
- Chiara Cattaneo,
- Tatiana Zollner,
- Lorenzo Masina,
- Samuele Bagnasco,
- Elisa Cerqui,
- Francesca Federico,
- Chiara Pagani,
- Silvana Archetti,
- Duilio Brugnoni,
- Giuseppe Rossi,
- Alessandra Tucci
Affiliations
- Carlotta Giupponi
- Hematology, ASST Spedali Civili
- Diego Bertoli
- Clinical Chemistry Laboratory, ASST Spedali Civili
- Erika Borlenghi
- Hematology, ASST Spedali Civili
- Chiara Cattaneo
- Hematology, ASST Spedali Civili
- Tatiana Zollner
- Hematology, ASST Spedali Civili
- Lorenzo Masina
- Hematology, ASST Spedali Civili
- Samuele Bagnasco
- Hematology, ASST Spedali Civili
- Elisa Cerqui
- Hematology, ASST Spedali Civili
- Francesca Federico
- Hematology, ASST Spedali Civili
- Chiara Pagani
- Hematology, ASST Spedali Civili
- Silvana Archetti
- Clinical Chemistry Laboratory, ASST Spedali Civili
- Duilio Brugnoni
- Clinical Chemistry Laboratory, ASST Spedali Civili
- Giuseppe Rossi
- Hematology, ASST Spedali Civili
- Alessandra Tucci
- Hematology, ASST Spedali Civili
- DOI
- https://doi.org/10.1038/s41408-023-00959-8
- Journal volume & issue
-
Vol. 13,
no. 1
pp. 1 – 4
Abstract
No abstracts available.
